Oculis Holding AG

Oculis Holding AGverified

OCS

Price:

$11.09

Market Cap:

$504.96M

Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which tar...[Read more]

Industry

Biotechnology

IPO Date

2021-05-18

Stock Exchange

NASDAQ

Ticker

OCS

The PE Ratio as of June 2026 (TTM) for Oculis Holding AG (OCS) is -5.26

According to Oculis Holding AG’s latest financial reports and current stock price. The company's current PE Ratio is -5.26. This represents a change of -45.99% compared to the average of -9.74 of the last 4 quarters.

Oculis Holding AG (OCS) Historical PE Ratio (quarterly & annually)

How has OCS PE Ratio performed in the past?

The mean historical PE Ratio of Oculis Holding AG over the last ten years is -10.27. The current -5.26 PE Ratio has changed 5.02% with respect to the historical average. Over the past ten years (40 quarters), OCS's PE Ratio was at its highest in in the March 2023 quarter at -1.22. The PE Ratio was at its lowest in in the September 2021 quarter at -14.81.

Quarterly (TTM)
Annual

Average

-10.27

Median

-8.34

Minimum

-18.91

Maximum

-3.18

Oculis Holding AG (OCS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Oculis Holding AG PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 128.67%

Maximum Annual PE Ratio = -3.18

Minimum Annual Increase = -59.73%

Minimum Annual PE Ratio = -18.91

Quarterly (TTM)
Annual
YearPE RatioChange
2025-8.7720.71%
2024-7.27128.67%
2023-3.18-59.73%
2022-7.90-49.35%
2021-15.59-17.55%

Oculis Holding AG (OCS) Average PE Ratio

How has OCS PE Ratio performed in the past?

The current PE Ratio of Oculis Holding AG (OCS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.41

5-year avg

-8.54

10-year avg

-10.27

Oculis Holding AG (OCS) PE Ratio vs. Peers

How is OCS’s PE Ratio compared to its peers?

Oculis Holding AG’s PE Ratio is greater than Xencor, Inc. (-5.38), greater than Kodiak Sciences Inc. (-9.13), greater than AnaptysBio, Inc. (-60.06), greater than UroGen Pharma Ltd. (-11.19), greater than Phathom Pharmaceuticals, Inc. (-5.41), greater than Nurix Therapeutics, Inc. (-6.32), greater than Nektar Therapeutics (-9.29), less than Sana Biotechnology, Inc. (-3.07), less than BridgeBio Oncology Therapeutics Inc. (-1.57), greater than Mind Medicine (MindMed) Inc. (-11.34),

Build a custom stock screener for Oculis Holding AG (OCS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oculis Holding AG using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oculis Holding AG (OCS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oculis Holding AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Oculis Holding AG's PE Ratio?

How is the PE Ratio calculated for Oculis Holding AG (OCS)?

What is the highest PE Ratio for Oculis Holding AG (OCS)?

What is the 3-year average PE Ratio for Oculis Holding AG (OCS)?

What is the 5-year average PE Ratio for Oculis Holding AG (OCS)?

How does the current PE Ratio for Oculis Holding AG (OCS) compare to its historical average?